Taiwan FDA registration e5dad098f1d66903dca8f7d1fc230ab4
Bondis Oppro C-reactive protein assay kit
TW: 邦迪斯歐普羅C-反應蛋白分析套組
Taiwan·Risk Class 2·THE BINDING SITE GROUP LTD·Registered Feb 04, 2020 – Feb 04, 2030ActiveRegistration details
- Analysis ID
- e5dad098f1d66903dca8f7d1fc230ab4
- Customs Code
- DHA05603326407
Company information
- Manufacturer
- THE BINDING SITE GROUP LTD
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product is used with the Binding Site Plite Analyzer for in vitro quantitative analysis of C-reactive protein (CRP) concentration in human serum, heparin lithium salt, or EDTA anticoagulant plasma.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5270 C反應蛋白免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Feb 04, 2020
- Expiry Date
- Feb 04, 2030
About this record
Access comprehensive regulatory information for Bondis Oppro C-reactive protein assay kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e5dad098f1d66903dca8f7d1fc230ab4 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices